The remote examination company is shifting focus from low-acuity primary care toward cardiopulmonary and oncology support
tytocare.comLinkedInNew York, USAHealthtechFounded 2012
6 sources
Sources agree that this was a $25 million-plus growth round announced on July 15, 2026, led by Insight Partners. The company's release is more specific about participating investors and states that TytoCare is headquartered in New York and Netanya, Israel; the roundup uses the abbreviated amount "$25M+" and does not list the additional participants.
2 sources
The source states $205 million as TytoCare’s total funding to date, not as this round’s financing total. No formal stage or valuation is stated.
1 source
The release says the valuation doubled but does not state its value. The $100M figure covers funding raised over the preceding 10 months, not this extension alone.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source states that Ping An Global Voyager Fund led the nearly $25 million Series C round announced the previous year, so it is not listed as a lead or participant in this additional $9 million tranche. The source also states that the total Series C round reached $33.5 million; the round amount here is only the additional $9 million.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source supports the stated amount, Series C stage, and 2018-01-29 announcement date. It additionally names Ping An as a new investor and identifies Ping An Insurance Group Company of China’s Global Voyager Fund as the lead investor.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source states that Cambia led the $11m series B and says the identities of the other series B investors were not disclosed. OrbiMed Israel Partners, LionBird, Fosun Pharma, and Walgreens are described as investors in earlier financing, not this round.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Growth [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $25M | 2026-07-15 | Insight Partners | No recent discussion |
6 sources [ VERIFIED ] read against 6 sources Sources agree that this was a $25 million-plus growth round announced on July 15, 2026, led by Insight Partners. The company's release is more specific about participating investors and states that TytoCare is headquartered in New York and Netanya, Israel; the roundup uses the abbreviated amount "$25M+" and does not list the additional participants. | ||||
TytoCare makes handheld, FDA-cleared examination devices and AI software that let health systems, payers and care programs deliver clinical-grade remote physical exams at home or in community sites.
Checked against 10 sources on Sep 24
| Growth additional growth funding [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $49M | 2023-08-03 | Insight Partners | No recent discussion |
2 sources [ VERIFIED ] read against 1 of 2 sources The source states $205 million as TytoCare’s total funding to date, not as this round’s financing total. No formal stage or valuation is stated. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: tytocare.com, globenewswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 of 2 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Series D+ ext. Series D extension [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M $100M to date | 2021-03-04 | Insight Partners | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source
The release says the valuation doubled but does not state its value. The $100M figure covers funding raised over the preceding 10 months, not this extension alone. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: prnewswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $9M | 2019-01-16 | not stated | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source
The source states that Ping An Global Voyager Fund led the nearly $25 million Series C round announced the previous year, so it is not listed as a lead or participant in this additional $9 million tranche. The source also states that the total Series C round reached $33.5 million; the round amount here is only the additional $9 million. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: tytocare.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $25M | 2018-01-29 | Global Voyager Fund | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The source supports the stated amount, Series C stage, and 2018-01-29 announcement date. It additionally names Ping An as a new investor and identifies Ping An Insurance Group Company of China’s Global Voyager Fund as the lead investor. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: mobihealthnews.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $11M | 2015-07-29 | Cambia Health Solutions | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The source states that Cambia led the $11m series B and says the identities of the other series B investors were not disclosed. OrbiMed Israel Partners, LionBird, Fosun Pharma, and Walgreens are described as investors in earlier financing, not this round. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: globalventuring.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| D Round | $50M | 2020-04 | Insight Partners, Olive Tree Ventures, Qualcomm Ventures | |
Also named as backers in company research: Ping An Global Voyager Fund, Teuza